Log In
BCIQ
Print this Print this
 

AS1402 (formerly R1550)

Also known as: huHMFG1 (formerly Therex)

  Manage Alerts
Collapse Summary General Information
Company Biothera Inc.
DescriptionHumanized mAb against MUC-1
Molecular Target Mucin 1 (MUC1) (CD227)
Mechanism of ActionAntibody
Therapeutic ModalityBiologic: Antibody
Latest Stage of DevelopmentPhase II
Standard IndicationBreast cancer
Indication DetailsTreat locally advanced or metastatic breast cancer
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

0

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

03/10/2011

Undisclosed

Undisclosed

Undisclosed

Get a free BioCentury trial today